BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 25, 2002
View Archived Issues
Chiron Reports Strong Earnings, Cuts Three Late-Stage Programs
Chiron Corp. reported robust third-quarter earnings, topping the Street's estimate by 14 cents per share, but also said it was dropping three late-stage programs, leaving some questioning the depth of its pipeline. (BioWorld Today)
Read More
OSI Drops Diabetes Program, Puts Full Focus On Oncology
Read More
Estren, Novel Hormone Substitute, Obviates Menopausal Bone, Breast Cancer Adversities - So Far In Mice
Read More
Amylin Pulls Symlin Filing In Europe; Problem Not Identified
Read More
Other News To Note
Read More
Vertex Expects Regulatory Filing For HIV Drug On Phase III Data
Read More
Appointments And Advancements
Read More